(Q35560941)

8 August 2017

1 reference

title

Paraneoplastic syndromes involving the nervous system (English)

1 reference

https://api.crossref.org/works/10.1056/NEJMRA023009

8 August 2017

Paraneoplastic Syndromes Involving the Nervous System (English)

1 reference

nervous system paraneoplastic syndrome

21 March 2024

main subject

nervous system

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561798

21 March 2024

1

Robert B. Darnell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561798

21 March 2024

author name string

Jerome B. Posner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561798

21 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

8 August 2017

16 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14561798

full work available at URL

21 March 2024

http://www.nejm.org/doi/pdf/10.1056/NEJMra023009

1 reference

https://api.crossref.org/works/10.1056/NEJMRA023009

The New England Journal of Medicine

21 March 2024

published in

1 reference

8 August 2017

349

1 reference

8 August 2017

1543-1554

1 reference

8 August 2017

16

1 reference

Poorly differentiated colon carcinoma with neuroendocrine features presenting with hypercalcemia and cutaneous metastases: case report and review of the literature

8 August 2017

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1097/00000421-200204000-00011

Cancer anorexia-cachexia syndrome: current issues in research and management

https://api.crossref.org/works/10.1056/NEJMRA023009

1

1 reference

Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

3

1 reference

Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

5

1 reference

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

6

1 reference

Paraneoplastic brain stem encephalitis in a woman with anti-Ma2 antibody.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

7

1 reference

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

8

1 reference

Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

9

1 reference

Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

10

1 reference

Cancer-associated retinopathy

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

11

1 reference

Bilateral optic neuropathy with IgGkappa multiple myeloma improved after myeloablative chemotherapy

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

12

1 reference

Response to cancer therapy in a patient with a paraneoplastic choreiform disorder.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

13

1 reference

Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

14

1 reference

Paraneoplastic syndromes of the spinal cord, nerve, and muscle

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

15

1 reference

Paraneoplastic myelopathy: antibodies against protein in normal spinal cord and underlying neoplasm

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

16

1 reference

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-1988. A 40-year-old man with rapidly progressive blindness and multiple cranial-nerve deficits

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

17

1 reference

Motor neuron disease and malignancy

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

18

1 reference

Subacute motor neuronopathy: a remote effect of lymphoma

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

19

1 reference

The stiff man and stiff man plus syndromes

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

20

1 reference

Paraneoplastic stiff limb syndrome

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

21

1 reference

Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

22

1 reference

Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

23

1 reference

Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

24

1 reference

Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

25

1 reference

Paraneoplastic Brachial Plexopathy in a Patient With Hodgkin's Disease

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

26

1 reference

Small-cell carcinoma of the lung presenting with paraneoplastic peripheral nerve microvasculitis and optic neuropathy

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

27

1 reference

Acquired neuromyotonia and peripheral neuropathy in a patient with Hodgkin's disease

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

28

1 reference

Understanding neuromyotonia

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

29

1 reference

The Lambert-Eaton myasthenic syndrome

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

30

1 reference

Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

31

1 reference

Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

32

1 reference

Paraneoplastic necrotizing myopathy: clinical and pathological features

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

33

1 reference

21 March 2024

Paraneoplastic myotonia

https://api.crossref.org/works/10.1056/NEJMRA023009

34

1 reference

Neurologic disorders in patients with small cell lung cancer.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

35

1 reference

Malignant thymoma associated with autoimmune diseases: a retrospective study and review of the literature

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

36

1 reference

Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

37

1 reference

Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

38

1 reference

[18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

39

1 reference

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

40

1 reference

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

41

1 reference

Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

42

1 reference

The case for a descriptive generic nomenclature: clarification of immunostaining criteria for PCA-1, ANNA-1, and ANNA-2 autoantibodies.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

43

1 reference

Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

44

1 reference

HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

45

1 reference

Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

46

1 reference

A hippocampal protein associated with paraneoplastic neurologic syndrome and small cell lung carcinoma

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

47

1 reference

Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

48

1 reference

Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

50

1 reference

The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

51

1 reference

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

52

1 reference

Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

53

1 reference

The fate of chronic in-patients after closure of psychiatric nursing homes in Norway: a personal follow-up 6 years later.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

54

1 reference

Investigative Ophthalmology Visual Science

21 March 2024

55

42

705

Maeda T

2001

1 reference

https://api.crossref.org/works/10.1056/NEJMRA023009

A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

56

1 reference

Investigative Ophthalmology Visual Science

21 March 2024

57

33

2768

Thirkill CE

1992

1 reference

https://api.crossref.org/works/10.1056/NEJMRA023009

Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

58

1 reference

The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

59

1 reference

Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

60

1 reference

CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

61

1 reference

Molecular and clinical diversity in paraneoplastic immunity to Ma proteins

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

62

1 reference

ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

63

1 reference

Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

64

1 reference

Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

65

1 reference

Phenotypic variants of autoimmune peripheral nerve hyperexcitability

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

66

1 reference

Paraproteinemic neuropathies

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

67

1 reference

Absence of HuD gene mutations in paraneoplastic small cell lung cancer tissue.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

68

1 reference

Spontaneous neurological improvement in anti-Hu associated encephalomyelitis

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

69

1 reference

A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

70

1 reference

Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

72

1 reference

Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

73

1 reference

Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

74

1 reference

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

75

1 reference

Poor outcome in patients with advanced stage neuroblastoma and coincident opsomyoclonus syndrome

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

76

1 reference

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

77

1 reference

Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer?A quantitative western blot analysis

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

78

1 reference

Tumor-specific killer cells in paraneoplastic cerebellar degeneration.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

79

1 reference

T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

80

1 reference

The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

81

1 reference

Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

82

1 reference

Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

83

1 reference

Broken dogma: penetration of autoantibodies into living cells

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

84

1 reference

Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

85

1 reference

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

87

1 reference

Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

88

1 reference

Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

89

1 reference

Regulation of class I MHC gene expression in the developing and mature CNS by neural activity

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

91

1 reference

Paraneoplastic opsoclonus-myoclonus associated with renal cell carcinoma and responsive to tumour ablation

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

92

1 reference

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

93

1 reference

Mycophenolate mofetil in the therapy of severe myasthenia gravis

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

94

1 reference

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

21 March 2024

https://api.crossref.org/works/10.1056/NEJMRA023009

95

1 reference

21 March 2024

Identifiers

DOI

10.1056/NEJMRA023009

1 reference

8 August 2017

1 reference